JOB POSTING: Clinical Trials Unit Manager at BC Children’s hem/onc – available immediately.

For a detailed job description, pay scale, and to apply, go to www.staffcareers.ubc.ca/26811

Qualifications: Undergraduate degree in a relevant discipline. Post-graduate degree in related discipline or equivalent professional designation preferred. Certified Clinical Research Professional through SoCRA or ACRP preferred. Minimum of three years experience or the equivalent combination of education and experience. Additional qualifications listed in posting.

Job Summary: To oversee clinical trials unit operations and ensure the highest ethical and regulatory standards are followed while conducting clinical trials at BC Children’s Hospital.

This position is the functional interface between the Director/Principal Investigators in the Division of Oncology/Hematology/BMT and the Clinical Trials Unit (CTU). This position will be the providing vision and will be responsible for developing and strategically planning programs from conception to completion as well as managing clinical multi-research, multi-disciplinary projects the operational clinical trials manager within the Division of Pediatric Hematology/Oncology/BMT and Childhood Cancer and Blood Research Cluster.

The individual will be accountable for the execution of clinical protocols within the allocated budget, personnel resources and timelines and will bring operational knowledge to the translation of clinical research protocols into practice. The individual will contribute to the leadership of the department by providing guidance and direction to colleagues to ensure the successful achievement of the department goals and milestones. The individual will also maintain a high level of current knowledge in clinical trials in order to provide expertise to different parts of the Clinical Research Support Group.

In addition to areas of the hospital, outpatient visits are performed in the clinical offices, and research recording and communication occurs with the research office. Attendance at clinical rounds and study meetings occur frequently and travel to international conferences and study meetings may occur. The manager attends study and other meetings along with or on behalf of the Director and Research Program Manager.

 

 

NEW⇒C17 Operating and Ewing Sarcoma Grant Competition. Registration due 08-Sep-17. Grants due 29-Sep-17. All areas of research welcome. Spread the word!!

C17 is pleased to announce a SUPPLEMENTAL GRANT COMPETITION for both the C17 Research Network Operating Grant Competition (Round 20) and the Ewing Sarcoma Grant Competition (Round 5). This competition does not replace the regular fall competition.  It is an additional funding opportunity.

The C17 operating grant competition is focused on multicenter, multidisciplinary pediatric oncology/hematology research. The Ewing Sarcoma Competition is focused on research with a direct application into the causes, treatment, cure and quality of life for young people with Ewing Sarcoma.

Forms and documents can be found attached as linked above, and can be downloaded from www.c17.ca/council-and-administrators/research/ under Committees> Research Network.

If you have any questions, please contact the C17 Research Network Coordinator, Leah C. Young, Ph.D.  leah.young2 (at) ahs.ca

CAN YOU RECOGNIZE THE SYMPTOMS OF THE DICER1 SYNDROME? New DICER1 online resource physicians and patients, including variant maps, biobanking instructions and genetic testing. www.dicer1syndrome.ca

With over 50 years of combined research experience, clinician-researchers Dr. William Foulkes and Dr. David Malkin, are pleased to introduce a new resource for patients and healthcare professionals interested in learning more about DICER1 syndrome. Until now, our research has contributed to allowing caregivers recognize the major features of the syndrome, counsel families about the mutation status in their families, and offer surveillance for certain conditions that can occur in those carrying DICER1 mutations. However, due to the rarity of DICER1 syndrome and related tumors, the study of DICER1 syndrome has been limited by the number of cases which occur. This Canadian research network will work to provide an international resource for the dissemination of the information that has been learned about DICER1 syndrome (available in English, French, and Spanish), a DICER1 sample database available for researchers at no cost, and a tool for broadening our reach for case and specimen collection. Please visit our website (www.dicer1syndrome.ca) or contact Evan Weber (evan.weber2@mail.mcgill.ca) for more information.

JOB POSTING: Research Program Manager at UBC/BC Children’s Hospital (open until filled, immediate start available)

The University of British Columbia, Department of Pediatrics, located at BCCH is seeking a Research Program Manager to provide strategic direction of the and MCCCRP and CCBR Group at the BC Children’s Hospital Research Institute in close collaboration with the program director, Dr. Kirk Schultz. You will be responsible for the overall planning, development, management, coordination, and communication for a large multiple-project clinical research program and laboratory research program; facilitation and management of research grants; writing reports and presentations for various stakeholders; developing drafts of manuscripts for publication; management of human
resources and financial administration; and contributing to the development of future research and programmatic activities.

The successful candidate will hold a Post-graduate degree or equivalent professional designation, a MSc or PhD is preferred. 4 years or equivalent combination of education and experience is required including experience in conducting clinical and laboratory research. Experience in financial management and human resource management is preferred. Experience with project management for multiple-site projects, research grants and contracts an asset.

Review of applications will commence immediately. Interested applicants should submit a letter and their curriculum vitae to:

Kirk R. Schultz, MD, FCAHS
Director, Michael Cuccione Childhood Cancer Research Program
Professor of Pediatrics, UBC
BC Children’s Hospital and Research Institute
4480 Oak Street, Rm. B315
Vancouver, BC V6H 3V4

e-mail: kschultz@mail.ubc.ca

Applications will be accepted until the position is filled. The anticipated start date is as soon as possible.  For a complete job description, please see pediatrics.med.ubc.ca/about/careers or med-fom-pediatrics.sites.olt.ubc.ca/files/2013/11/Research-Program-Manager.pdf


The University of British Columbia (UBC) is Canada’s third largest university and consistently ranks among the 40 best universities in the world. Primarily situated in Vancouver, UBC is a research-intensive university and has an economic impact of $4 billion to the provincial economy. The UBC Faculty of Medicine educates health professional and life sciences students at the undergraduate, graduate and postgraduate levels, and pursues research – in the laboratory, in clinical settings and at the population and public policy level – to improve the health of people worldwide.

BC Children’s Hospital (BCCH) cares for the province’s most acutely ill or injured children and youth and pediatric patients with chronic medical disorders, and provides developmental and rehabilitation services to children and youth throughout BC. BCCH offers a wide range of health services and specialized health programs, is a leading acute care teaching facility, and conducts research to advance health and care through the BC Children’s Hospital Research Institute, in partnership with the UBC. The pediatric residency program and 16 pediatric subspecialty training programs are accredited by the Royal College of Physicians and Surgeons of Canada.

The Michael Cuccione Childhood Cancer research program (MCCCRP) is a program focused on improving the efficacy and safety of the treatment of childhood, adolescent, and young adult cancers. It focuses on developing targeted interventions including drug and immune therapies that include cell therapies including blood and marrow transplantation. Moreover there is a major focus on improving the safety of current therapies to lead to a minimum amount of late effects. The Childhood and Cancer and Blood (CCBR) group includes the MCCCRP as well as research focused on all blood disorders including transplantation and cell therapies for non-cancer diseases. The program is provincial in its scope and provides national and international leadership. The MCCCRP included 10 clinical trials PIs and 6 laboratory based PIs. The clinical trials program includes 7 clinical fellows, 10 CRAs and RNs with 3 managers as part of the program structure and the laboratory based program includes 40 trainees, RAs, post-doctoral fellows, and project coordinators. The CCBR include an additional 15 PIs involved in blood and cancer research. The approximate annual operating budget is $2M.

The INUIT CANCER EXPERIENCE depicted in “Jon’s Tricky Journey” (storybook+ educational resource) by Pat McCarthy, and funded by C17 with CCCF. All sites to receive copies. See full posting for book website with previews of this stunning book.

From the author, Pat McCarthy:

 

Hello everyone! This is my first e-mail blast to family, friends and colleagues. I wanted to let you know that my book has been published by Inhabit Media and is available on Amazon.com (US),  and on Indigo books (Canada). The amazon and indigo websites say release date of Sept 1 2017, however the books should be arriving in the Inhabit Media warehouse this week, and will be available sooner. The book is bilingual; English and Inuktitut.

My website is:  www.jonstrickyjourney.vistaprintdigital.com

Inhabit Media website:  http://inhabitmedia.com/2017/06/05/jons-tricky-journey/

This book was supported with a grant from C17,  in partnership with Childhood Cancer Canada Foundation, and with support from the Children’s Hospital of Eastern Ontario.


Jon loves his life in the North. But when he feels a pain that won’t go away, he must go to a children’s hospital in the south to find out what is wrong. A doctor there tells Jon he has cancer and will have to stay at the hospital for a while.

Suddenly Jon’s life is upside down! But with a handful of tricks from the doctors and nurses, and new friends, Jon discovers ways to cope with some of the tricky parts of having cancer.

Accompanied by a resource guide for parents and caregivers, including hospital and support information, Jon’s Tricky Journey opens a conversation between Inuit children facing a cancer diagnosis and their families to help make a difficult and confusing time more manageable.

Written by Patricia McCarthy | Illustrated by Hwei Lim

ISBN: 978-1-77227-145-4 | $19.95 | 8.5″ x 8.5″ | 70 pages | Full-colour illustrations | Paperback | Bilingual Inuktitut and English

Ages 5–7

NEW AGENTS & INNOVATIVE THERAPY PROGRAM – June newsletter available

The NAIT June newsletter is available here: NAIT Newletter June 2017
The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical

JOB POSTING: Clinical Academic position in Clinical Paediatric Hematoloty-Oncology at Children’s Hospital/Western University (London, ON)

Department of Paediatrics, Western University, Schulich School of Medicine & Dentistry

 

The Department of Paediatrics, Children’s Hospital, London Health Sciences Centre and Schulich School of Medicine & Dentistry, Western University, is seeking a fully certified Paediatric Haematologist-Oncologist to join our established Division of Paediatric Haematology-Oncology. The Division of Paediatric Haematology-Oncology provides comprehensive haematology and oncology care for the children of southwestern Ontario population of about 2 million.

Western University delivers an academic experience second to none.  Western challenges the best and brightest faculty, staff and students to commit to the highest global standards.  Our research excellence expands knowledge and drives discovery with real-world application.  Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.  Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities.  Western is a research-intensive institution with a wide range of academic and professional programs (see http://www.uwo.ca/ to learn more).  Western’s Recruitment and Retention Office is available to assist in the transition of successful applicants and their families.

Candidates for this position must have an MD or equivalent degree and must be eligible for licensing in the Province of Ontario.  Subspecialty certification in Paediatric Haematology-Oncology from the Royal College of Physicians and Surgeons of Canada or equivalent is required.  Additional training in patient safety and management of adverse events during therapy is desired.  The successful candidate will be a Clinician Teacher, and hold a full-time Limited Term Clinical Academic appointment at the rank of Assistant Professor or Associate Professor, or a Continuing Clinical Academic appointment at the rank of Associate Professor or Professor, depending upon qualifications and experience at the time of appointment.  Successful candidates will have a keen interest in academic medicine, the ability to collaborate effectively with all other members of the health care team and office staff, and will be expected to participate in team-based health care and teaching, both at the undergraduate and postgraduate levels.

Compensation for this position will be primarily composed of an alternative funding plan and academic salary. The anticipated start date for this position is to be negotiated.

Please submit your application, including curriculum vitae, Letter of Interest/Statement of Academic Qualifications, and names and contact information of three references to:

Michael Rieder, MD, PhD, FRCPC
Professor of Paediatrics, Interim Chair/Chief, Department of Paediatrics
800 Commissioners Road East, London, Ontario, Canada N6A 5W9
Email: mrieder@uwo.ca

 Applications will be accepted until the position is filled.  Review of applications will begin on Tuesday, July 4, 2017.  Please ensure that the form http://uwo.ca/facultyrelations/physicians/Application_FullTime_Clinical.pdf is included in your application.

Business Addresses:

  • Western University, 1151 Richmond Street N., London, Ontario N6A 5B8, www.uwo.ca
  • London Health Sciences Centre, 800 Commissioners Road East, London Ontario, N6A 5W9, www.lhsc.on.ca
  • St. Joseph’s Health Care London, 268 Grosvenor Street, London, Ontario, N6A 4V2, www.sjhc.london.on.ca

 

Positions are subject to budget approval. Applicants should have fluent written and oral communication skills in English. The University invites applications from all qualified individuals. Western is committed to employment equity and diversity in the workplace and welcomes applications from women, members of racialized groups/visible minorities, Aboriginal persons, persons with disabilities, persons of any sexual orientation, and persons of any gender identity or gender expression.

 In accordance with Canadian Immigration requirements, priority will be given to Canadian citizens and permanent residents. Accommodations are available for applicants with disabilities throughout the recruitment process. If you require accommodations for interviews or other meetings, please contact Jill O’Dowda at jodowda@uwo.ca or 519-685-8129.

Want to celebrate Clinical Trials Day (May 20), but don’t know what to do? Read here to download a printable poster and videos from N2 and ItStartsWithMe.ca. Share at your site or on social media

  • Print out the poster below by clicking here and post it at your site this week to engage and inform patients and the public about why we celebrate Clinical Trials Day.
  • Share the “It Starts With Me” video about clinical trials through e-mail and social media, or play it on televisions in waiting rooms. This brief, 1-minute video gives individuals an overview of the potential benefits of clinical trials and information on how they can get involved. You can see the video in English here and in French here.
  • Join our “Ask Me” campaign by contacting Dawn Richards, our Business Development Specialist, at dawn.richards@n2canada.ca, and create dialogue at your site around clinical trials and how to get involved.

Happy Clinical Trials Day, and a huge thank you to all clinical research professionals for your contributions to public health and medical progress!

Public Comments on the Proposed Changes to TCPS 2 ( 2014)

Public Comments on the Proposed Changes to TCPS 2 ( 2014)

In October 2016, the Panel on Research Ethics released proposed changes to TCPS 2 (2014) to the public for comment. Written comments were accepted until January 31, 2017. All comments received have been posted to the Panel’s website unless the contributor requested that they remain confidential.

This valuable feedback will now be taken into consideration as the Panel and Secretariat prepare recommendations to the federal research Agencies (CIHR, NSERC and SSHRC) that are responsible for approving revisions to TCPS 2 (2014).

STUDY SPOTLIGHT: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement (COG AALL15P1)

This pilot trial studies the side effects of azacitidine and combination chemotherapy in infants with acute lymphoblastic leukemia and KMT2A gene rearrangement.

  • Official Title: A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
  • NOL Date: Canadian NOL 05-May-2017
  • Cooperative Group: Children’s Oncology Group
  • NCT02828358, COG  Protocol AALL15P1
  • For more information see: https://clinicaltrials.gov/ct2/show/NCT02828358